RIGL R&D Expenses
Rigel Pharmaceuticals Inc · R&D Expenses
RIGL R&D Expenses
Latest reported$43.68Mperiod ending
RIGL TTM R&D Expenses ($32.03M → $43.68M)
TTM R&D Expenses
High-resolution chart · PNG
RIGL r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 43,675,000 | |
| 36,535,000 | |
| 33,295,000 | |
| 28,242,000 | |
| 27,071,000 | |
| 25,790,000 | |
| 23,380,000 | |
| 20,934,000 | |
| 21,227,000 | |
| 20,459,000 | |
| 24,522,000 | |
| 36,701,000 | |
| 44,892,000 | |
| 54,887,000 | |
| 60,272,000 | |
| 58,211,000 | |
| 61,845,000 | |
| 63,885,000 | |
| 65,237,000 | |
| 67,071,000 | |
| 63,371,000 | |
| 60,778,000 | |
| 60,101,000 | |
| 59,210,000 | |
| 59,073,000 | |
| 58,085,000 | |
| 52,885,000 | |
| 52,405,000 | |
| 49,039,000 | |
| 46,610,000 | |
| 46,903,000 | |
| 44,697,000 | |
| 44,408,000 | |
| 45,135,000 | |
| 46,269,000 | |
| 46,342,000 | |
| 51,705,000 | |
| 57,649,000 | |
| 63,446,000 | |
| 68,375,000 | |
| 67,705,000 | |
| 65,296,000 | |
| 62,825,000 | |
| 60,875,000 | |
| 61,525,000 | |
| 66,529,000 | |
| 67,696,000 | |
| 71,129,000 | |
| 72,552,000 | |
| 71,882,000 | |
| 75,328,000 | |
| 77,046,000 | |
| 79,658,000 | |
| 81,189,000 | |
| 78,778,000 | |
| 78,833,000 | |
| 75,963,000 | |
| 72,148,000 | |
| 69,350,000 | |
| 63,289,000 | |
| 62,367,000 | |
| 62,073,000 | |
| 64,392,000 | |
| 70,809,000 | |
| 75,497,000 | |
| 83,630,000 | |
| 90,743,000 | |
| 98,970,000 | |
| 109,120,000 | |
| 112,588,000 | |
| 109,670,000 | |
| 103,228,000 | |
| 87,368,000 | |
| 76,141,000 | |
| 70,364,000 | |
| 63,406,000 | |
| 62,084,000 | |
| 58,100,000 | |
| 56,968,000 | |
| 55,348,000 | |
| 54,974,000 | |
| 55,576,000 | |
| 52,038,000 | |
| 50,951,000 | |
| 50,541,000 | |
| 48,002,000 | |
| 48,523,000 | |
| 47,894,000 | |
| 45,617,000 | |
| 45,047,000 | |
| 43,363,000 | |
| 41,266,000 | |
| 41,901,000 | |
| 43,269,000 | |
| 43,350,000 | |
| 42,699,000 | |
| 39,706,000 | |
| 36,427,000 | |
| 32,313,000 | |
| 55,429,000 |